| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/12/2009 | EP2086564A1 Peptide-containing pharmaceutical and/or cosmetic composition |
| 08/12/2009 | EP2086533A2 Use of an adenosine antagonist |
| 08/12/2009 | EP2086528A2 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases |
| 08/12/2009 | EP2086521A2 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 08/12/2009 | EP2086507A1 A spinal nucleus pulposus implant |
| 08/12/2009 | EP2086506A2 Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy |
| 08/12/2009 | EP2086331A2 Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 08/12/2009 | EP2086321A2 Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| 08/12/2009 | EP1949906A4 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 08/12/2009 | EP1924278A4 A kit of lyophilized thrombin and lyophilized fibrinogen used to compound fibrin membrane, and its application |
| 08/12/2009 | EP1909820A4 Modulation of granulosa cell apoptosis |
| 08/12/2009 | EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 08/12/2009 | EP1888094B1 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 08/12/2009 | EP1880733A4 Method for increasing longevity of a human being and animals |
| 08/12/2009 | EP1832296B1 Compositions based on Midkine for the treatment of chronic stage injury of the heart after ischemia/reperfusion |
| 08/12/2009 | EP1819729B8 Method for producing carboxy-terminal amidified peptides |
| 08/12/2009 | EP1819355A4 Methods of using chimeric coiled-coil molecule |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 08/12/2009 | EP1635854A4 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| 08/12/2009 | EP1587520B1 Bacteriophage for the treatment of bacterial biofilms |
| 08/12/2009 | EP1559432B1 Hm1.24-utilizing cancer vaccines |
| 08/12/2009 | EP1556067A4 Phenolic binding peptides |
| 08/12/2009 | EP1550672B1 Chimeric antagonist anth1 |
| 08/12/2009 | EP1525478B1 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3-expressing tumors |
| 08/12/2009 | EP1514116B1 Oxaliplatin anti-resistance method |
| 08/12/2009 | EP1465912B9 Chimeric tnf ligands |
| 08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
| 08/12/2009 | EP1424895B1 Method for expression of small antiviral rna molecules within a cell |
| 08/12/2009 | EP1401376A4 Colloidal metal compositions and methods |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1351705B1 Compositions for treatement of hemorrhaging with activated factor viia in combination with fibrinogen |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP1198589B9 Tenascin-c nucleic acid ligands |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP1127944B9 Methods for screening compounds inhibiting inflammatory cytokine production |
| 08/12/2009 | EP1090133B1 Production of il-10 in non-food crop plant bioreactor |
| 08/12/2009 | EP0898580B9 Methods and means for inhibition of cdk4 activity |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | EP0771322B9 Abundant extracellular products and methods for their production and use |
| 08/12/2009 | CN101506364A SDF-I binding nucleic acids |
| 08/12/2009 | CN101506359A Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
| 08/12/2009 | CN101506238A Methods and compositions with enhanced therapeutic activity |
| 08/12/2009 | CN101506234A Identification and use of GPRC variants in the treatment and diagnosis of Parkinson's disease |
| 08/12/2009 | CN101506225A Cardioprotective compounds |
| 08/12/2009 | CN101506224A Peptide epoxyketones for proteasome inhibition |
| 08/12/2009 | CN101506223A 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 08/12/2009 | CN101505796A Soft tissue repair and regeneration using stem cell products |
| 08/12/2009 | CN101505790A Treatment of ocular diseases |
| 08/12/2009 | CN101505789A A stable liquid formulation of human growth hormone |
| 08/12/2009 | CN101505788A Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 08/12/2009 | CN101505787A Treatment of cartilage disorders |
| 08/12/2009 | CN101505786A A novel peptide involved in energy homeostasis |
| 08/12/2009 | CN101505785A Use of tenecteplase for treating acute ischemic stroke |
| 08/12/2009 | CN101505784A Cyclic natriuretic peptide constructs |
| 08/12/2009 | CN101505783A Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 08/12/2009 | CN101505782A Methods and compositions for conserving and/or preparing an organ or tissue for transplant |
| 08/12/2009 | CN101505781A Lactoferrin as a radioprotective agent |
| 08/12/2009 | CN101505780A Treatment of development-related disorders |
| 08/12/2009 | CN101505723A Collagen scaffolds, medical implants with same and methods of use |
| 08/12/2009 | CN101505722A Flowable carrier matrix |
| 08/12/2009 | CN101505608A Polyphenol/peptide composition |
| 08/12/2009 | CN101503727A Hyriopsis cumingii enzymolysis polypeptide, as well as preparation and application thereof |
| 08/12/2009 | CN101503672A Composition of cytokine and use thereof |
| 08/12/2009 | CN101503474A Human vascular endothelial cell growth inhibition factor jogged polypeptide, preparation thereof and use in targeted antineoplastic activity |
| 08/12/2009 | CN101503461A Polypeptide with liver cancer apoptosis reducing function |
| 08/12/2009 | CN101503459A Bloody noun antibacterial peptide temporin-Lb, genes thereof and use in pharmacy |
| 08/12/2009 | CN101503458A Small molecule polypeptide for preventing and treating angiogenesis and use thereof |
| 08/12/2009 | CN101503457A Column chromatography PEG and interferon analogue protein N-terminal site-directed coupling method and product thereof |
| 08/12/2009 | CN101502649A Liposome influenza vaccine |
| 08/12/2009 | CN101502647A Medicament composition for preventing or/and treating decayed tooth and preparation method thereof |
| 08/12/2009 | CN101502646A Preparation for female body shaping and gynaecological inflammation and method for producing the same |
| 08/12/2009 | CN101502645A Compound medicament for treating malignant pleuroperitoneal cavity dropsy and use thereof |
| 08/12/2009 | CN101502644A Applications of hCRF and derivatives thereof in preparing medicament for treating alveolar hypoventilation syndrome |
| 08/12/2009 | CN101502643A Applications of hCRF and derivatives thereof in preparing medicament for treating Guillain Barre syndrome |
| 08/12/2009 | CN101502642A Use of hepatitis B virus x protein and encoding gene thereof in preparing medicament for treating cancer of liver |
| 08/12/2009 | CN101502641A Ciclosporin medicament composition for injection administration |
| 08/12/2009 | CN101502640A Compound dipeptide pharmaceutical formulations and preparation method thereof |
| 08/12/2009 | CN101502639A Glycyl-L-tyrosine pharmaceutical formulations and preparation method thereof |
| 08/12/2009 | CN101502638A Glycyl-L-glutamine pharmaceutical formulation and preparation method thereof |
| 08/12/2009 | CN101502489A Intestinal nutrient solution with special medical goal |
| 08/12/2009 | CN100526463C Methods for making Apo-2 ligand using divalent metal ions |
| 08/12/2009 | CN100526332C Application of endothelium inhibitant for preducing medicament for retina disease therapy |
| 08/12/2009 | CN100526309C Dimeric compounds and their use as anti-viral agents |
| 08/12/2009 | CN100525834C Gene engineering preparation method of human pancreas secreted trypsin inhibitor |
| 08/12/2009 | CN100525833C A method for forming dextran 40/polypeptide freeze dried powder injection solution |
| 08/12/2009 | CN100525832C Chaperonin 10 immunosuppression |
| 08/12/2009 | CN100525831C Improved pharmaceutical botulinum toxin compositions |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525829C Method for detecting ligands and targets in a mixture |
| 08/12/2009 | CN100525782C Tetraselmis chui polysaccharide protein possessing antineoplastic function |
| 08/11/2009 | US7573601 Digital camera |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572894 Preparing a fibrous protein smectic hydrogel by way of a solvent templating process |
| 08/11/2009 | US7572892 Cytokine zalpha11 ligand fusion proteins |
| 08/11/2009 | US7572891 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 08/11/2009 | US7572890 Having activities to inhibit Hemagglutination by Influenza Viruses; lacks dihydrofolate reductase, possesses resistance to both neomycin and methotrexate |
| 08/11/2009 | US7572887 Gene expressed in prostate cancer, methods and use thereof |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572885 Isolated GAGE-7B and 8 proteins |
| 08/11/2009 | US7572884 Method for making acylated polypeptides |